Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

5/7/25 New Sentri7 Rule

May 7, 2025

Pharmacists,

A new Sentri7 rule has been created in the "Clinical Alerts" tab to help identify patients on ceftriaxone 1 g who are eligible to be increased to 2 g per our recently approved policy. 

The following guidance is listed in the comments section of the rule. 

Per P&T, pharmacists can automatically dose adjust ceftriaxone based on severity of infection--ADULTS only, round up ONLY
Cystitis and cellulitis: Ceftriaxone 1-2 g acceptable, if BMI >30 then 2 g; if ceftriaxone 2 g is ordered, make no changes
Infections outside of the urinary tract or more involved than skin alone: Ceftriaxone 2 g; if ceftriaxone 1 g is ordered, increase the dose to 2 g regardless of BMI 
 
Please let us know if you have any questions. 

Thank you, 
Morgan S. Stone, Pharm.D., BCPS
Supervisor, Pharmacy Professional Services
Huntsville Hospital, Department of Pharmacy
morgan.stone@hhsys.org
Cell: 334.303.2365






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved